muscle
• reduction in myogenic precursor marker Pax7 peptide level and 50% reduction in Pax7+ myogenic precursor cells in E16.5 embryos
• significantly reduced levels of committed myoblast markers MyoD and myogenin peptide levels and 60% reduction in MyoD+ myoblasts in E16.5 embryos
• 7x increased MyHC-slow peptide levels in E16.5 embryos
|
cellular
N |
• normal apoptosis in E16.5 embryos
|